Myriad Genetics | MYGN - Net Income

Stock Price
4.74
Daily Change
0.07 1.50%
Monthly
-1.46%
Yearly
-38.68%
Q2 Forecast
4.61

Myriad Genetics reported $-7.9M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 305M 129M Dec/2025
Becton, Dickinson and Co. USD 382M 111M Dec/2025
Bio-Rad Laboratories USD -341.9M 659.7M Sep/2025
Bruker USD 26M 88.4M Dec/2025
Danaher USD 1.2B 289M Dec/2025
Hologic USD 179.1M 8.2M Dec/2025
Illumina USD 334M 184M Dec/2025
J&J USD 5.12B 36M Dec/2025
Mettler Toledo International USD 285.76M 68.27M Dec/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Quest Diagnostics USD 245M 0 Dec/2025
Quidel USD -733M 477.6M Sep/2025
Repligen USD 13.29M 1.62M Dec/2025
Revvity USD 98.36M 51.71M Dec/2025
Standard Biotools USD 19.28M 53.97M Dec/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Veracyte USD 41.15M 22.01M Dec/2025
Waters USD 225.21M 76.29M Dec/2025